Cyr61 inhibitors target and modulate the activity of the Cyr61 protein. Cyr61, also known as CCN1, belongs to the CCN (Cyr61/CTGF/Nov) family of matricellular proteins, which are secreted into the extracellular matrix and play multifaceted roles in cellular functions and tissue remodeling. Cyr61 is involved in diverse cellular processes, and its functions are mediated through interactions with various cell surface receptors, such as integrins and heparan sulfate proteoglycans. Upon binding to these receptors, Cyr61 triggers intracellular signaling pathways that modulate cellular responses to extracellular cues. It is an essential regulator of processes like cell adhesion, migration, proliferation, and survival. Additionally, Cyr61 plays a pivotal role in angiogenesis, the formation of new blood vessels from pre-existing ones, which is crucial for tissue growth and repair. Cyr61 inhibitors are specifically designed to disrupt the interactions between Cyr61 and its cellular receptors, disrupting the transmission of intracellular signals that would typically be initiated by Cyr61 binding. By doing so, these inhibitors can interfere with downstream gene expression and cellular responses that are influenced by Cyr61's activities.
The chemical structures of Cyr61 inhibitors may vary significantly, as researchers continually refine and optimize these compounds to enhance their selectivity and efficacy in modulating Cyr61's functions. The exact mechanisms by which Cyr61 inhibitors interact with Cyr61 and inhibit its activity can also differ based on their specific molecular properties. The targeted modulation of Cyr61 activity by these inhibitors has proven to be an invaluable tool in basic research. By using Cyr61 inhibitors, scientists can delve into the intricate regulatory networks that govern various cellular processes, shedding light on the significance of Cyr61 in normal physiological functions. Cyr61 inhibitors represent a specialized chemical class of compounds designed to selectively target Cyr61 and disrupt its interactions with cellular receptors. Through this targeted modulation, these inhibitors offer valuable tools for researchers to investigate the multifaceted roles of Cyr61 in cellular processes, tissue homeostasis, and angiogenesis, contributing to the advancement of knowledge in various fields of cellular biology.
VOIR ÉGALEMENT...
| Nom du produit | CAS # | Ref. Catalogue | Quantité | Prix HT | CITATIONS | Classement |
|---|---|---|---|---|---|---|
NSC 632839 hydrochloride | 157654-67-6 | sc-204138 sc-204138A | 10 mg 50 mg | $119.00 $465.00 | ||
Inhibe l'expression de COL2A1 et la synthèse du collagène de type II, réduisant ainsi la dégradation du cartilage et le remodelage de la matrice extracellulaire dans les maladies articulaires telles que l'arthrose. | ||||||
SB-3CT | 292605-14-2 | sc-205847 sc-205847A | 1 mg 5 mg | $100.00 $380.00 | 15 | |
Inhibe la transcription du gène COL2A1 et l'activation des MMP-2/9, atténuant ainsi la dégradation du cartilage et les processus inflammatoires associés à l'arthrose. | ||||||
Celastrol, Celastrus scandens | 34157-83-0 | sc-202534 | 10 mg | $155.00 | 6 | |
Réduit l'expression de COL2A1 et des cytokines pro-inflammatoires, atténuant la destruction du cartilage dans l'arthrite grâce à ses propriétés anti-inflammatoires. | ||||||
Chondroitinase ABC from Proteus vulgaris | 9024-13-9 | sc-507341 | 2 U | $650.00 | ||
Clivage des chaînes de glycosaminoglycanes sur l'aggrécane, modulant le renouvellement de COL2A1 et le remodelage de la matrice dans les processus de réparation du cartilage. | ||||||
Heat Shock Protein Inhibitor I | 218924-25-5 | sc-221709 | 5 mg | $95.00 | 5 | |
Inhibe indirectement la Hsp70, réduisant l'expression de COL2A1 et apportant potentiellement des bénéfices thérapeutiques dans l'arthrite et d'autres troubles liés au collagène. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $182.00 $693.00 | 88 | |
Bloque les protéines kinases associées à Rho (ROCK), régulant potentiellement la synthèse de COL2A1 et améliorant la fibrose et les troubles du cartilage. | ||||||
KN-93 | 139298-40-1 | sc-202199 | 1 mg | $178.00 | 25 | |
Inhibe la protéine kinase II dépendante du Ca2+/calmoduline (CaMKII), atténuant l'expression de COL2A1 et les voies liées au collagène dépendant du calcium. | ||||||
Piperine | 94-62-2 | sc-205809 sc-205809A | 5 g 25 g | $36.00 $143.00 | 3 | |
Régule à la baisse COL2A1 et les cytokines inflammatoires, ce qui pourrait atténuer la dégradation du cartilage dans l'arthrite grâce à ses propriétés anti-inflammatoires. | ||||||